Biostatistics and Epidemiology Flashcards
7 cards from real NBME practice questions. Tap to flip, then mark Knew It or Still Learning — missed cards come back until you master them.
Read the first 7 Biostatistics and Epidemiology flashcards as text
The specificity of a diagnostic test is BEST defined as:
Answer: True negatives / (True negatives + False positives)
Specificity = TN / (TN + FP); it measures the proportion of truly disease-free individuals who test negative (the true negative rate).
A meta-analysis reports an odds ratio of 2.5 (95% CI: 1.8–3.4) for the association between smoking and lung cancer. Which conclusion is CORRECT?
Answer: Statistically significant because the 95% CI does not cross 1.0
When a 95% confidence interval for an odds ratio or relative risk does not include 1.0, the result is statistically significant at the α = 0.05 level.
A case-control study asks patients to recall dietary habits from 10 years ago. The type of bias MOST likely introduced is:
Answer: Recall bias
Recall bias occurs when cases systematically remember or report past exposures differently from controls, distorting the measured association.
The standard error of the mean (SEM) is calculated as:
Answer: Standard deviation divided by the square root of n
SEM = SD / √n; it estimates how much the sample mean would vary across repeated samples drawn from the same population.
A rapid strep test is compared to throat culture (gold standard). It is positive in 95 of 100 culture-positive patients and negative in 90 of 100 culture-negative patients. What is the sensitivity of the rapid test?
Answer: 95%
Sensitivity = TP / (TP + FN) = 95 / 100 = 95%; it captures 95% of truly infected patients.
In a normal distribution, approximately what percentage of values fall within 2 standard deviations of the mean?
Answer: 95%
The empirical rule states that ~68% of data falls within 1 SD, ~95% within 2 SD, and ~99.7% within 3 SD of the mean.
Lead-time bias in cancer screening studies results in:
Answer: Apparent prolongation of survival without actual improvement in the time of death
Lead-time bias inflates measured survival time because screening detects disease earlier, but if the natural history is unchanged, patients simply know about their disease longer without living longer.